company background image
A237690 logo

ST PharmLtd KOSDAQ:A237690 Stock Report

Last Price

₩88.20k

Market Cap

₩1.7t

7D

0.6%

1Y

20.3%

Updated

27 Mar, 2024

Data

Company Financials +

A237690 Stock Overview

ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.

A237690 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance2/6
Financial Health4/6
Dividends1/6

ST Pharm Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ST PharmLtd
Historical stock prices
Current Share Price₩88,200.00
52 Week High₩99,000.00
52 Week Low₩59,900.00
Beta0.69
1 Month Change33.43%
3 Month Change30.09%
1 Year Change20.33%
3 Year Change3.40%
5 Year Change300.91%
Change since IPO80.74%

Recent News & Updates

Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

Mar 22
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Mar 18
ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Recent updates

Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

Mar 22
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Mar 18
ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Mar 16
Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

Jan 22
Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Dec 23
What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

Nov 26
Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

Shareholder Returns

A237690KR Life SciencesKR Market
7D0.6%-1.7%3.8%
1Y20.3%6.2%13.0%

Return vs Industry: A237690 exceeded the KR Life Sciences industry which returned 6.2% over the past year.

Return vs Market: A237690 exceeded the KR Market which returned 13% over the past year.

Price Volatility

Is A237690's price volatile compared to industry and market?
A237690 volatility
A237690 Average Weekly Movement10.1%
Life Sciences Industry Average Movement7.3%
Market Average Movement5.3%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A237690's share price has been volatile over the past 3 months.

Volatility Over Time: A237690's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1983645Peter Kimhttps://www.stpharm.co.kr

ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical R and D solutions.

ST Pharm Co.,Ltd. Fundamentals Summary

How do ST PharmLtd's earnings and revenue compare to its market cap?
A237690 fundamental statistics
Market cap₩1.66t
Earnings (TTM)₩19.58b
Revenue (TTM)₩284.99b

84.7x

P/E Ratio

5.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A237690 income statement (TTM)
Revenue₩284.99b
Cost of Revenue₩175.25b
Gross Profit₩109.74b
Other Expenses₩90.16b
Earnings₩19.58b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.04k
Gross Margin38.51%
Net Profit Margin6.87%
Debt/Equity Ratio48.8%

How did A237690 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

81%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.